Abstract:Hydrogen sulfide, once considered as toxic gas, is now recognized as an important biological mediator. The deficiency of hydrogen sulfide could lead to various pathological changes, such as arterial and pulmonary hypertension, Alzheimer's disease, gastric mucosal injury and liver cirrhosis. However, excessive production of hydrogen sulfide, by using inorganic hydrogen sulfide donors such as NaHS, may contribute to the pathogenesis of inflammatory diseases, septic shock, cerebral stroke and mental retardation in patients with Down syndrome. Therefore, an increasing interest in organic molecules that are capable of regulating the formation of hydrogen sulfide has extended in recent years. Allium vegetables are one natural source of organic sulfur-containing compounds and have been widely investigated regarding their therapeutic applications, and it has been proven that the ingredients of garlic, such as diallyl disulfide, diallyl trisulfide and S-ally cysteine act as hydrogen sulfide donors or mediators in pharmaceutical studies. In addition, S-propargyl cysteine (ZYZ-802) and S-propyl cysteine, two synthetic cysteine analogs, have been examined and could be used to treat ischemic heart disease via modulation of the hydrogen sulfide pathway. In addition, drugs containing hydrogen sulfide-releasing moieties have been synthesized and widely reported in recent years, such as S-nonsteroidal anti-inflammatory drugs and the derivative of Lawesson's reagents, which exhibit varied biological effects in experiments. As cystathionine β-synthase and cystathionine γ-lyase are the enzymes that are able to catalyze the production of endogenous hydrogen sulfide from cysteine, their inhibitors, such as dl-propylargylglycine and β-cyanoalanine, have been frequently used in studies on the biological mechanism of hydrogen sulfide. All these hydrogen sulfide donors, mediators and inhibitors have provided useful tools in the research of a variety of biological effects and are promising drug candidates of hydrogen sulfide.

Naturally occurring organosulfur for treating metabolic disorders and infectious diseases

Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators.

The importance of sulfur-containing motifs in drug design and discovery

Converting organosulfur compounds to inorganic polysulfides against resistant bacterial infections

Antibacterial Properties of Organosulfur Compounds of Garlic (Allium sativum)

Organoselenium compounds in medicinal chemistry

Chemistry and Biochemistry of Sulfur Natural Compounds: Key Intermediates of Metabolism and Redox Biology

Enzymatic Carbon-Sulfur Bond Formation in Natural Product Biosynthesis

Insights into the Superior Bioavailability of Biogenic Sulfur from the View of Its Unique Properties: the Key Role of Trace Organic Substances.

Drugs and Their Mode of Action: A Review on Sulfur-Containing Heterocyclic Compounds

Glutathione-Garlic Sulfur Conjugates: Slow Hydrogen Sulfide Releasing Agents for Therapeutic Applications

Generation and Physiology of Hydrogen Sulfide and Reactive Sulfur Species in Bacteria

Health Benefits of Plant-Derived Sulfur Compounds, Glucosinolates, and Organosulfur Compounds

Glucosinolate derivatives as antifungals: A review

Immunomodulatory Effects of Glutathione, Garlic Derivatives, and Hydrogen Sulfide

Hydrogen Sulfide Metabolite, Sodium Thiosulfate: Clinical Applications and Underlying Molecular Mechanisms

An Appraisal of Developments in Allium Sulfur Chemistry: Expanding the Pharmacopeia of Garlic

The intriguing chemistry and biology of sulfur-containing natural products from marine microorganisms (1987–2020)

Sulfur (SVI)-containing heterocyclic hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA) and its SAR

Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter

Organosulfur Compounds in Colorectal Cancer Prevention and Progression